While covered entities await a final decision on Medicare Part B cuts, as well as potential changes to the 340B program, lawmakers and the administration are poised to act on health care legislation as soon as this summer. Voters are particularly concerned about the high cost of care, which remains the top issue on the minds of Americans – ahead of immigration, the economy, national security, climate change and other hot button topics.

Get the latest on the fast-moving developments affecting the 340B program during PSG’s breakfast forum on July 15th from 7 - 8 a.m. at the Marriott Wardman. Speakers include three top health care leaders and observers in drug pricing policy and cost management. The forum will address:

  • Key 340B developments on Capitol Hill and at the state level
  • The administration’s next moves on drug pricing
  • Efforts to drive pricing transparency for covered entities
  • How the dynamic PBM landscape is impacting your organization and your patients
  • A new 340B grassroots group and its game plan for protecting the program


Dave Borden, Chief Executive Officer
Pharmaceutical Strategies Group

Ted Slafsky, Founder & Principal
Wexford Solutions LLC

Peggy Tighe, Principal, Powers Law
Ryan White Clinics for 340B Access

July 15, 2019

7 - 8 a.m. EST



Join us in DC for a breakfast forum on
drug pricing developments

Register today to reserve your seat. Space is limited, so act fast!

Marriot Wardman Park

2446 18th St NW
Washington, DC 20009


*Details included in confirmation email